Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Rare syndrome raises transplant cancer risk: new study aims to find out why

NCT ID NCT07605884

First seen May 31, 2026 · Last updated Jun 17, 2026 · Updated 3 times

Summary

This study compares children with Denys-Drash syndrome who received a kidney transplant to other young kidney transplant patients. The goal is to see if the syndrome increases the risk of a type of cancer called post-transplant lymphoproliferative disorder. Researchers will review medical records from French hospitals to identify risk factors and improve future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DENYS-DRASH SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Montpellier

    Montpellier, 34000, France

  • CHU de Lille

    Lille, 59000, France

    Contact Email: •••••@•••••

  • CHU de Nancy - Hôpitaux de Brabois

    Nancy, 54500, France

  • Hôpital Femme Mère Enfant, Hospices Civils de Lyon

    Bron, 69500, France

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • Hôpital Necker-Enfants Malades

    Paris, 75015, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital Robert Debré

    Paris, 75019, France

    Contact Email: •••••@•••••

  • Hôpital enfants et adolescents, CHU Nantes

    Nantes, 44093, France

    Contact Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

Denys-Drash syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.